Regular aspirin use and gene expression profiles in prostate cancer patients

[1]  Jennifer R. Rider,et al.  Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer , 2017, Cancer.

[2]  Jacob K. Asiedu,et al.  The Drug Repurposing Hub: a next-generation drug library and information resource , 2017, Nature Medicine.

[3]  Bin Liu,et al.  Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator , 2017, Cellular Physiology and Biochemistry.

[4]  Jennifer R. Rider,et al.  Perineural Invasion and Risk of Lethal Prostate Cancer , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[5]  M. Stampfer,et al.  Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study. , 2016, European urology.

[6]  L. Mucci,et al.  Common medications and prostate cancer mortality: a review , 2017, World Journal of Urology.

[7]  Jennifer R. Rider,et al.  Prognostic Utility of a New mRNA Expression Signature of Gleason Score , 2016, Clinical Cancer Research.

[8]  E. Whitlock,et al.  Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force , 2016, Annals of Internal Medicine.

[9]  Yin Cao,et al.  Aspirin and colorectal cancer: the promise of precision chemoprevention , 2016, Nature Reviews Cancer.

[10]  Jihye Kim,et al.  DSigDB: drug signatures database for gene set analysis , 2015, Bioinform..

[11]  M. Pollak,et al.  The use of aspirin and the risk of mortality in patients with prostate cancer. , 2015, The Journal of urology.

[12]  Juancarlos Chan,et al.  Gene Ontology Consortium: going forward , 2014, Nucleic Acids Res..

[13]  S. Freedland,et al.  Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Peter Kraft,et al.  Association of Prostate Cancer Risk Variants with Gene Expression in Normal and Tumor Tissue , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[15]  R. Spitale,et al.  Molecular targets of aspirin and cancer prevention , 2014, British Journal of Cancer.

[16]  Morten Wang Fagerland,et al.  Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. , 2014, European urology.

[17]  L. Sharp,et al.  A cohort study investigating aspirin use and survival in men with prostate cancer. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  Peter Kraft,et al.  Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations. , 2013, Journal of the National Cancer Institute.

[19]  L. Bateman,et al.  An alkyne-aspirin chemical reporter for the detection of aspirin-dependent protein modification in living cells. , 2013, Journal of the American Chemical Society.

[20]  T. Uchiumi,et al.  Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells. , 2013, Endocrine-related cancer.

[21]  D. Powe,et al.  Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink , 2013, Cancer Causes & Control.

[22]  Stacey A. Kenfield,et al.  Aspirin Use after a Prostate Cancer Diagnosis and Cancer Survival in a Prospective Cohort , 2012, Cancer Prevention Research.

[23]  Anthony V D'Amico,et al.  Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Parmar,et al.  Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial , 2012, The Lancet. Oncology.

[25]  P. Rothwell,et al.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials , 2011, The Lancet.

[26]  Gary D Bader,et al.  Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.

[27]  Wenyan Lu,et al.  Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation. , 2009, European journal of pharmacology.

[28]  Yong J. Lee,et al.  Aspirin Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis in Hormone-Refractory Prostate Cancer Cells through Survivin Down-Regulation , 2007, Molecular Pharmacology.

[29]  Yan Liu,et al.  Risk factors for prostate cancer incidence and progression in the health professionals follow‐up study , 2007, International journal of cancer.

[30]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[31]  Y. Kwon,et al.  Pretreatment of Acetylsalicylic Acid Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis by Down-regulating BCL-2 Gene Expression* , 2005, Journal of Biological Chemistry.

[32]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Hess,et al.  Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin , 2005, Cancer.

[34]  B. Pittman,et al.  Regression of Mouse Prostatic Intraepithelial Neoplasia by Nonsteroidal Anti-inflammatory Drugs in the Transgenic Adenocarcinoma Mouse Prostate Model , 2004, Clinical Cancer Research.

[35]  D. Sliva,et al.  Aspirin inhibits highly invasive prostate cancer cells. , 2003, International journal of oncology.

[36]  R. Rotem,et al.  Contrasting effects of aspirin on prostate cancer cells: Suppression of proliferation and induction of drug resistance , 2000, The Prostate.

[37]  X. Chen,et al.  Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Deane,et al.  Identifiable factors in post-prostatectomy haemorrhage: the role of aspirin. , 1990, British journal of urology.

[39]  Final report on the aspirin component of the ongoing Physicians' Health Study. , 1989, The New England journal of medicine.

[40]  P. Amrein,et al.  Aspirin-induced prolongation of bleeding time and perioperative blood loss. , 1981, JAMA.